Resultado de búsqueda
In 1930 Theiler moved to the Rockefeller Foundation in New York, where he later became director of the Virus Laboratory and where he spent the rest of his career.When Theiler began at Harvard it was still a matter of controversy whether yellow fever was a viral infection, as Walter Reed had claimed in 1901, or whether it was due to Leptospira icteroides, the bacillus discovered by Hideyo ...
19 de sept. de 2019 · Yellow fever is a major public health problem. A live attenuated vaccine, developed by Max Theiler and colleagues in the 1930s,1 has helped to control yellow fever, but the duration of protective immunity has been questioned.
1 de abr. de 2017 · Max Theiler (1899–1972): Creator of the yellow fever vaccine. Yellow fever is a tropical disease that was once a major cause of gastrointestinal bleeding, liver failure and death for both civilians and soldiers in the Americas. Credit for conquering the disease goes to Cuban epidemiologist Carlos Finlay and United States (US) army surgeon ...
Aquí nos gustaría mostrarte una descripción, pero el sitio web que estás mirando no lo permite.
The yellow fever vaccine produced at Fiocruz (previously Oswaldo Cruz Institute) is still the 17D attenuated strain, and the vaccine department proudly preserves the first vials of the vaccine from 1937. In 2021, this vaccine is manufactured at the ultra-modern glass-and-steel building of Bio-Manguinhos, but this is a relatively new development.
13 de abr. de 2017 · In 1937, virologist Max Theiler developed a live attenuated yellow fever vaccine that is still in use today and that provides lifetime immunity in up to 99% of vaccinees, according to the World ...
In 1937 Max Theiler, Hugh Smith and Eugen Haagen develop the 17D vaccine against yellow fever. The vaccine is approved in 1938 and over a million people have receive it that year. Theiler goes on to be awarded the Nobel Prize.
